DONG-A ST CO.,LTD Logo

DONG-A ST CO.,LTD

Develops, manufactures, and markets drugs, medical devices, and diagnostics.

170900 | KO

Overview

Corporate Details

ISIN(s):
KR7170900005
LEI:
Country:
South Korea
Address:
서울 동대문구 용두동 138 ~255 천호대로 64, 서울

Description

Dong-A ST CO., LTD. is a pharmaceutical company focused on the research, development, manufacturing, and marketing of ethical drugs, medical devices, and diagnostics. The company's portfolio includes proprietary new drugs such as Stillen (gastritis), Zydena (erectile dysfunction), and Motilitone (functional dyspepsia). Operating from cGMP-compliant facilities, it exports a diverse range of products, including novel drugs, generics, and biopharmaceuticals, to global markets. The company maintains a strong commitment to innovative R&D, with a pipeline featuring first-in-class therapeutic candidates for metabolic diseases, including MASH (Metabolic dysfunction-associated steatohepatitis) and obesity, which are being advanced through a dedicated global R&D base.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2026-01-02 00:00
주식등의대량보유상황보고서(약식)
Korean HTML 62.4 KB
2025-12-16 00:00
주주명부폐쇄기간또는기준일설정
Korean HTML 5.6 KB
2025-09-09 00:00
투자설명서
Korean HTML 2.8 MB
2025-09-09 00:00
증권발행실적보고서
Korean HTML 47.8 KB
2025-09-08 00:00
[발행조건확정]증권신고서(채무증권)
Korean HTML 14.6 KB
2025-09-03 00:00
[기재정정]증권신고서(채무증권)
Korean HTML 3.1 MB
2025-09-03 00:00
[발행조건확정]증권신고서(채무증권)
Korean HTML 275.8 KB
2025-08-28 00:00
증권신고서(채무증권)
Korean HTML 2.8 MB
2025-08-14 00:00
반기보고서 (2025.06)
Korean HTML 3.3 MB
2025-08-13 00:00
[기재정정]영업(잠정)실적(공정공시)
Korean HTML 18.0 KB
2025-07-25 00:00
주식등의대량보유상황보고서(일반)
Korean HTML 239.2 KB
2025-07-24 00:00
영업(잠정)실적(공정공시)
Korean HTML 13.8 KB
2025-07-24 00:00
기업설명회(IR)개최(안내공시)
Korean HTML 6.6 KB
2025-07-18 00:00
결산실적공시예고(안내공시)
Korean HTML 4.1 KB
2025-07-18 00:00
기업설명회(IR)개최(안내공시)
Korean HTML 6.8 KB

Automate Your Workflow. Get a real-time feed of all DONG-A ST CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DONG-A ST CO.,LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DONG-A ST CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.